Toxoplasma gondii
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1058790 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Purpose: To shed light on the parasiticidal mechanisms of Altiratinib, we have adapted a workflow which combines a forward genetic approach based on transcriptome sequencing, computational mutation discovery and CRISPR/Cas9 genome editing in Toxoplasma gondii. Drug-resistant parasites were generated by chemical random mutagenesis. Multiple independent resistant lines were isolated. Single nucleotide variations (SNVs) were identified based on NGS transcriptomic analysis. By focusing on mutations present in coding sequences, we identified a single gene, TgPRP4K, that harbored SNVs leading to amino acid substitutions in 5 out of the 6 drug-resistant lines that were not present in the parental strain. Finally, using CRISPR/Cas9 genome editing we confirmed that the mutations identified confer resistance against Altiratinib.
2022-03-30 | GSE193614 | GEO
Project description:Mutant T. gondii parasites lacking the hexokinase gene were viable. We carried genome wide expression analysis to identify genes that are differentially expressed in the mutant parasite with reference to wild type parental line. For this microarray analysis, we used the Affymetrix Toxoplasma gondii Custom GeneChip (CDF: ToxoDB version 5); Further details for this array can be found in the GEO platform ID GPL10000
2017-08-11 | GSE102500 | GEO
Project description:Long read sequencing of Toxoplasma gondii parental strain and SPT mutants
| PRJNA821424 | ENA
Project description:TgFbxL2 interactome from Toxoplasma gondii tachyzoites were performed in 3 Biological Replicates, with 3 Technical Replicates each, by comparing FbxL2-HA tagged strain against parental, non-tagged strain.
2024-06-03 | PXD046583 | Pride
Project description:TgFbxO13 interactome from Toxoplasma gondii tachyzoites were performed in 2 Biological Replicates, with 3 Technical Replicates each, by comparing FbxO13-HA tagged strain against parental, non-tagged strain.
2024-09-23 | PXD049975 | Pride
Project description:TgFbxO14 interactome from Toxoplasma gondii tachyzoites were performed in 2 Biological Replicates, with 3 Technical Replicates each, by comparing FbxO14-HA tagged strain against parental, non-tagged strain.
2024-09-23 | PXD049694 | Pride
Project description:TgFbxO1 interactome from Toxoplasma gondii tachyzoites were performed in 5 Biological Replicates, with 2 Technical Replicates each, by comparing FbxO1-HA tagged strain against parental, non-tagged strain.
2024-09-23 | PXD050011 | Pride
Project description:Toxoplasma gondii is a zoonotic pathogen for which felids serve as definitive hosts. In cats, the parasite undergoes several rounds of asexual replication before entering the sexual cycle which gives rise to oocysts that are shed into the environment. These then sporulate and become infective to humans and live stock. To understand the genes involved in the parasite development in the felid host and identify potential intervention targets, we designed a transcriptomic approach to compare the cat intestinal stages with the well characterised tachyzoites that mediate acute infection and tissue cysts that are responsible for chronic infection. Cats were infected with T. gondii tissue cysts from mouse brain and sampled the intestinal stages at day 3, 5 and 7 post infection. As an input sample, we also collected tissue cysts from mouse brain as well as in vitro cultivated tachyzoites. Total RNA was extracted, enriched for mRNA and used for cDNA synthesis. RNA-Seq was then performed to describe the transcriptomic repertoire of each time point/life cycle stage.
2018-03-30 | GSE108740 | GEO
Project description:The Toxoplasma gondii rhoptry neck protein RON13 was first identified as a substrate of aspartyl protease 3 by Terminal Amine Isotopic Labelling of Substrates (TAILS8, Dogga et al. 2017). It harbours a kinase domain the activity of which is important for host cell invasion. To identify the targets of RON13, we engineered a transgenic T. gondii line in the RH ΔKu80 background exploiting the tetracycline repressor system (Meissner et al. 2001). Here, the change of promoter resulted in the overall downregulation of RON13 expression leading to parasites that display significantly diminished infection capability. This defect can be rescued by complementation with an active version of RON13 kinase. We have performed phosphopeptide enrichment and shotgun proteomics using the parental line and three mutant strains: RON13 knock-down (RON13-KD), RON13 knock-down complemented with wildtype RON13 as well as RON13 knock-down complemented with the catalytically dead kinase in which an essential aspartate was replaced by alanine. Comparison of the results between the parental line and RON13-KD allowed us to identify phosphosites that were differentially phosphorylated. Validation of those phosphosites was performed using the comparison between the two complemented lines with the active or the inactive versions of RON13.
2021-05-13 | PXD018056 | Pride
Project description:Virulence differences in Toxoplasma mediated by amplification of polymorphic pseudokinases.
| PRJNA132095 | ENA